Greater transparency needed in publishing information from clinical trials, experts say
Tuesday, January 29, 2013 - 21:00
in Health & Medicine
An initiative from the drugs regulator, the European Medicines Agency, to commit to releasing all of the information from clinical trials once the marketing authorization process has ended, which has been greeted with cautious optimism by proponents of access to data but with much less enthusiasm by the pharmaceutical industry, sparks an interesting debate on the role of medical journals in publishing drug data.